5'H-PREGNA-1,4-DIENO(17,16-D)OXAZOL-21-AL, 11-HYDROXY-2'-METHYL-3,20-DIOXO-, (11.BETA.,16.BETA.)-
UNII W5S5C9C8GJ
Substance Identification & Data
This profile provides standardized clinical and technical data for 5'h-pregna-1,4-dieno(17,16-d)oxazol-21-al, 11-hydroxy-2'-methyl-3,20-dioxo-, (11.beta.,16.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W5S5C9C8GJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3035569-86-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H27NO5 AVMGJZDNRTWZEK-RVUAFKSESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5'h-pregna-1,4-dieno(17,16-d)oxazol-21-al, 11-hydroxy-2'-methyl-3,20-dioxo-, (11.beta.,16.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.